Treatment patterns among US children and adolescents with recorded depressive disorders

OBJECTIVE: To characterize depression-linked treatment, annual trends, and factors associated with receipt of both psychotherapy and antidepressants among youths in the United States. METHODS: This repeated cross-sectional study used 2016-2023 Medical Expenditure Panel Survey data. The population included children and adolescents aged 6-17 years with depressive disorders. We linked condition records to psychotherapy visits and antidepressant fills, estimated survey-weighted treatment percentages, and used survey-weighted logistic regression to examine factors associated with receipt of both treatments during the same survey year. RESULTS: The analysis included 865 person-year observations, with adolescents comprising 90.3% of the weighted sample. Any treatment was recorded for 82.7% (95% confidence interval [CI], 79.6-85.7%), psychotherapy for 62.7%, and antidepressant treatment for 50.1%. Psychotherapy alone accounted for 32.5%, both treatments for 30.2%, and antidepressants alone for 20.0%. Neither treatment was recorded for 17.3%. The percentage receiving any treatment increased from 58.9% in 2016 to 89.8% in 2023 (P for trend < 0.001). Compared with non-Hispanic White youths, Hispanic and non-Hispanic Black youths had lower adjusted odds of receiving both modalities (0.44 [95% CI, 0.26-0.76] and 0.35 [95% CI, 0.13-0.89], respectively). Comorbid anxiety disorder and attention-deficit/hyperactivity disorder were associated with higher adjusted odds (1.54 [95% CI, 1.04-2.29] and 1.60 [95% CI, 1.07-2.41], respectively). CONCLUSIONS: More than one in six participants had neither depression-linked treatment recorded, and receipt of both treatments differed by race and ethnicity. Small subgroup sizes limited precision, particularly for younger children. The linked records measured treatment receipt without establishing clinical indication or adequacy.

Authors

Institutions

Publication Details

Journal
European Child & Adolescent Psychiatry
Published
2026-11-20
DOI
https://doi.org/10.1007/s00787-026-03256-4
Primary Topic
Mental Health Treatment and Access
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Treatment patterns among US children and adolescents with recorded depressive disorders

王秀丽, Olivia L. Ramey, Ligang Liu, Fuzhuo Wang et al.
European Child & Adolescent Psychiatry
Mental Health Treatment and Access
article

Treatment patterns among US children and adolescents with recorded depressive disorders

王秀丽, Olivia L. Ramey, Ligang Liu, Fuzhuo Wang, Xiaowen Sun
article en

Abstract

OBJECTIVE: To characterize depression-linked treatment, annual trends, and factors associated with receipt of both psychotherapy and antidepressants among youths in the United States. METHODS: This repeated cross-sectional study used 2016-2023 Medical Expenditure Panel Survey data. The population included children and adolescents aged 6-17 years with depressive disorders. We linked condition records to psychotherapy visits and antidepressant fills, estimated survey-weighted treatment percentages, and used survey-weighted logistic regression to examine factors associated with receipt of both treatments during the same survey year. RESULTS: The analysis included 865 person-year observations, with adolescents comprising 90.3% of the weighted sample. Any treatment was recorded for 82.7% (95% confidence interval [CI], 79.6-85.7%), psychotherapy for 62.7%, and antidepressant treatment for 50.1%. Psychotherapy alone accounted for 32.5%, both treatments for 30.2%, and antidepressants alone for 20.0%. Neither treatment was recorded for 17.3%. The percentage receiving any treatment increased from 58.9% in 2016 to 89.8% in 2023 (P for trend < 0.001). Compared with non-Hispanic White youths, Hispanic and non-Hispanic Black youths had lower adjusted odds of receiving both modalities (0.44 [95% CI, 0.26-0.76] and 0.35 [95% CI, 0.13-0.89], respectively). Comorbid anxiety disorder and attention-deficit/hyperactivity disorder were associated with higher adjusted odds (1.54 [95% CI, 1.04-2.29] and 1.60 [95% CI, 1.07-2.41], respectively). CONCLUSIONS: More than one in six participants had neither depression-linked treatment recorded, and receipt of both treatments differed by race and ethnicity. Small subgroup sizes limited precision, particularly for younger children. The linked records measured treatment receipt without establishing clinical indication or adequacy.

European Child & Adolescent Psychiatry
University of South Carolina (US), First Affiliated Hospital of Liaoning Medical University (CN), Jinzhou Medical University (CN), The University of Texas at Austin (US), Western University of Health Sciences (US)
Western University of Health Sciences
Good health and well-being, Reduced inequalities
Mental Health Treatment and Access
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon